{
    "eid": "2-s2.0-85151044137",
    "title": "Efficacy of Erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial",
    "cover-date": "2023-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Erbium YAG Laser",
        "OABSS",
        "Overactive bladder syndrome",
        "Vaginal atrophy"
    ],
    "authors": [
        "Keerati Chiengthong",
        "Suvit Bunyavejchevin"
    ],
    "citedby-count": 0,
    "ref-count": 46,
    "ref-list": [
        "An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction",
        "The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA",
        "Impact of overactive bladder on women in the United States: results of a national survey",
        "The epidemiology of overactive bladder among females in Asia: a questionnaire survey",
        "The burden of overactive bladder on US public health",
        "Prevalence of overactive bladder in China, Taiwan and South Korea: results from a cross-sectional, population-based study",
        "Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society",
        "Pathophysiology of Overactive Bladder",
        "Developments in our understanding of detrusor instability",
        "A neurologic basis for the overactive bladder",
        "Urothelial signaling",
        "Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms",
        "Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms",
        "The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction",
        "Diagnosis and treatment of overactive bladder (non-neurogenic) in adults:AUA/SUFUGuidelineAmendment 2019",
        "Laser therapy as a treatmentmodality for genitourinary syndrome of menopause: a critical appraisal of evidence",
        "Genitourinary syndrome ofmenopause and the use of laser therapy",
        "Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause",
        "Vaginal laser therapy for genitourinary syndrome of menopause-systematic review",
        "Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy",
        "Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment",
        "Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence",
        "Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and 3-adrenoceptor agonists",
        "An innovative dual-phase protocol for pulsed ablative vaginal Erbium:YAG laser treatment of urogynecological symptoms",
        "Ablative dual-phase Erbium: YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment",
        "Reliability of Thai-version Overactive Bladder Symptom Scores (OABSS) Questionnaire and the correlations of OABSS with voiding diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) questionnaires",
        "Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?",
        "Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score",
        "Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instrument in Psychology",
        "Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OABq",
        "The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder",
        "Are women with urogenital atrophy symptomatic?",
        "Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach",
        "Urogenital ageing: an old problem newly recognized",
        "Responsiveness and minimal clinically important change in overactive bladder symptom score",
        "Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score",
        "Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug",
        "What affects the placebo effect?",
        "Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause",
        "Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause",
        "Is overactive bladder microvasculature disease a component of systemic atheroscleorosis?",
        "Efficacy of fractional CO(2) laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial",
        "Efficacy of fractional CO(2) laser in the treatment of genitourinary syndrome of menopause in Latin-American Population: first Peruvian experience",
        "Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results",
        "Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? preliminary results"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": []
}